Methotrexate results in similar levels of 20% and 50% responses as cyclosporine, leflunomide, etanercept and infliximab in routine clinical care, according to an index of functional status, pain and patient global scores, the 3 Core Data Set measures for rheumatoid arthritis (RA) derived from patient self-report questionnaires.

被引：0

作者：

Pincus, T ^{[1
]}

Swearingen, C ^{[1
]}

Sokka, T ^{[1
]}

机构：

[1] Vanderbilt Univ, Nashville, TN USA

来源：

ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

799

引用

页码：S337 / S337

页数：1

共 7 条

[1] Methotrexate results in similar levels of 50% improvement after 6 months as cyclosporine, leflunomide, etanercept and infliximab in routine clinical care, according to a patient self-report index and erytrocyte sedimentation rate
Pincus, T
Swearingen, C
Sokka, T
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 266 - 266
[2] A simple Apgar-Like Patient Score (ALPS) based on 3 core data set patient questionnaire self-report measures, physical function, pain and global status, yields results similar to ACR 20 in a rheumatoid arthritis clinical trial
Pincus, T
Amara, I
Sokka, T
Koch, G
ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S315 - S315
[3] RAPID3, An Index of Only 3 Patient Self-report Core Data Set Measures, but not ESR, Recognizes Incomplete Responses to Methotrexate in Usual Care of Patients with Rheumatoid Arthritis
Pincus, Theodore
BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2013, 71 (02): : 117 - 120
[4] Higher Scores of Women Compared to Men for Most Clinical Measures of Rheumatoid Arthritis (RA) Status: Greater Differences for Patient Self-Report Scores Than for Rheumatologist Estimates: A Cross-Sectional 3 Center Study from Routine Care
Castrejon, Isabel
Bergman, Martin
Yazici, Yusuf
Huang, Annie
Block, Joel A.
Pincus, Theodore
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[5] A pooled index of patient questionnaire data discriminates between responses to leflunomide (LEF) or methotrexate (MTX) vs placebo at a 20% level as effectively as the disease activity index (DAS), ACR20, pooled index of non-patient questionnaire measures or all 7 core data set measures in a clinical trial of patients with rheumatoid arthritis (RA).
Pincus, T
Wolfe, F
Strand, V
Cohen, S
Crawford, B
Felson, D
ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S186 - S186
[6] An index of only 3 patient measures in the core data set calculated similarly to the ACR 20 index provides evidence similar to standard ACR 26, 50 and 70 responses of superior efficacy of leflunomide or methotrexate versus placebo in a Randomized controlled clinical trial.
Pincus, T
Amara, I
Koch, G
Strand, V
ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S245 - S245
[7] Routine Apgar-like patient index data (RAPID) score, an absolute index of the 3 patient-questionnaire-derived Core Data Set measures physical function, pain, global status: Performance of preliminary versions to distinguish active from placebo treatments in 4 adalimumab clinical trials.
Pincus, T
Sokka, T
Amare, I
Segurado, O
Koch, G
ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S554 - S554

← 1 →